Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 9457 - 9464 of 12008 results
Breaking Down the DOJ Cybersecurity Unit’s Guidance on Responding to Cyberattacks
May 7, 2015| Blog| Viewpoint
Quick Update on the Obama Administration's Efforts to Update the FLSA White Collar Exemptions
May 6, 2015| Blog| Viewpoint
EPA’s Proposed Nano Rule: What Should You Be Doing Now?
May 6, 2015| Blog| Viewpoint
Maximizing Use of the USPTO's Patent Application Alert Service
May 6, 2015| Blog| Viewpoint
Medicare Part D Data Release Continues Transparency Trend
May 6, 2015| Blog| Viewpoint
First Circuit Hears Oral Arguments on Validity of Puerto Rico's Recovery Act
May 6, 2015| Blog| Viewpoint
These Taxi Drivers Are Not Employees Says Massachusetts Supreme Judicial Court
May 5, 2015| Blog| Viewpoint
Massachusetts Attorney General’s Office Issues Much-Anticipated Proposed Regulations on Massachusetts Sick Time Law
May 5, 2015| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|